Biomaterials Business Segment - Heraeus Medical
The biomaterials and medical products business group (Heraeus Medical) concentrates on medical products for orthopedic surgery as well as traumatology and biosurgery. An industry leader for bone cements, the company de-velops, produces, and globally markets biomaterials used to anchor joint prostheses to bone and to stabilize spinal fractures. In the field of biosurgery, Heraeus Medical offers innovative antibiotic coatings for medical implants, thereby helping to prevent infections.
Heraeus Medical GmbH
Revenue: Euro 59.9 million
Employees: 173
(End of 2009)
Heraeus Medical GmbH
Philipp-Reis-Strasse 8 / 13
61273 Wehrheim, Germany
T: + 49 (0) 6181.35-3000
F: + 49 (0) 6181.35-3300
contact.medical@heraeus.com
CaSO4
Calcium sulfate (CaSO4) is a component of many biomaterials, which are playing an increasingly important role in the surgical treatment of bone and joint diseases. Heraeus specializes in the development of materials containing active ingredients for localized use in orthopedic surgery for a variety of indications. For example, our Palacos® bone cement has set the standard for over 50 years for firmly and reliably anchoring prostheses to bone in replacement joints. Whether a result of infection or traumatic injury, bone loss poses another serious challenge for surgeons. For this problem, orthopedic surgery utilizes innovative carrier materials that can be absorbed and transformed into the body’s own tissue. The goal is to completely repair bone defects while at the same time preventing infection.
CaSO4 (calcium sulfate) is a component of the Herafill® bone grafting material developed by Heraeus; the illustration shows a scanning electron microscope image of the biomaterial.
